Bryan Dechairo serves as Chief Operating Officer at GeneDx Holdings Corp Class A, a leading provider of genetic testing and diagnostics focused on pediatric and rare disease cases. With more than 20 years of experience in healthcare diagnostics and genomics, Dechairo brings a proven track record of scaling operations and driving commercial success in precision medicine. Prior to GeneDx, he was Chief Commercial Officer at Invitae Corporation, where he spearheaded revenue growth, expanded market share in hereditary cancer and cardiology testing, and navigated complex commercial strategies during a period of rapid expansion. Earlier in his career, Dechairo held the role of Senior Vice President and General Manager at PerkinElmer Genomics (now Revvity), where he led the division to multimillion-dollar achievements through innovative product launches, strategic partnerships, and operational optimizations. His leadership emphasized data-driven decision-making and cross-functional collaboration, resulting in enhanced service delivery and customer satisfaction in genomic sequencing services. At GeneDx, Dechairo oversees laboratory operations, commercial execution, supply chain, and customer experience, playing a central role in the company's shift toward profitability and innovation in exome and genome analysis. His strategic vision has accelerated diagnostic turnaround times, expanded access to advanced testing, and positioned GeneDx as a leader in delivering actionable insights for complex pediatric cases worldwide.